(Q92367919)
Statements
Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease (English)
Naomi Sugimura
Tsutomu Mizoshita
Tomoya Sugiyama
Shozo Togawa
Tomokatsu Miyaki
Taketo Suzuki
Satoshi Tanida
Hiromi Kataoka
19 February 2019